Search

everythinglearnresearchcommunity

for

Search:↓

Vitamin D receptor is important for regulating hair growth and wound healing in mice.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

Activating PKM2 and Wnt/β-catenin signaling speeds up wound healing.

Advancements in nanoformulations for CRISPR-Cas9 genome editing can respond to specific triggers for controlled gene editing, showing promise in treating incurable diseases, but challenges like precision and system design complexity still need to be addressed.

Removing the VDR gene in skin cells reduces their growth and affects hair-related genes.

CRISPR/Cas9 gene-editing shows promise for improving sheep and goat breeding but faces challenges with efficiency and accuracy.

Some rice types grow better roots for phosphorus uptake, but not all do.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Vitamin D Receptor is crucial for normal skin and hair growth.

Hairless protein can block vitamin D activation in skin cells.

Human stem cells can help form hair follicles in mice.

Overexpressing the MSX-2 gene in mice causes skin and hair growth issues.

Adding a second method to PROTACs could improve cancer treatment.

TTNPB helps turn stem cells into neural stem cells, improving depression-like behaviors in rats.

Personalized skin rejuvenation using genomics shows promise but needs more research.

A new genetic mutation in the TRPS1 gene causes Trichorhinophalangeal Syndrome, leading to specific hair, dental, and bone issues.

A new mutation in the TRPS1 gene caused Trichorhinophalangeal syndrome in a 17-year-old, highlighting the need for genetic testing.

About 50% of 46, XY DSD cases lack a genetic diagnosis, but advanced sequencing methods improve detection.

Activating the Sonic hedgehog gene in mice can start the hair growth phase.

Anabolic androgenic steroids can increase cancer risk and disrupt hormones.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Genetic testing for hairless gene mutations is crucial to correctly diagnose and treat atrichia with papular lesions.

A new mutation in the Hr gene causes hair loss in mice, similar to a human hair disorder.

Mutations in the NR3C1 gene cause a rare condition that affects hormone signaling and can lead to various symptoms, with dexamethasone as a treatment option.

Early diagnosis of Trichorhinophalangeal syndrome type 1 is crucial for treatment and was achieved through clinical examination and family history.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Antiandrogens may help prevent or treat COVID-19 by blocking virus entry into cells.

Myotonic Dystrophy may age cells faster, and drugs that target aging could be potential treatments.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Targeting protein S-palmitoylation could lead to new skin disease treatments.